These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 9097003)

  • 21. [Levels of some auto-antibodies and C-peptide in insulin-treated patients with diabetes mellitus (DM) depending on gender of the patients and disease duration].
    Likhonosov PN; Khalangot ND
    Lik Sprava; 2007; (5-6):50-5. PubMed ID: 18416165
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [C-peptide determination in diabetics for the evaluation of insulin requirements].
    Keller U; Pasquel M; Berger W
    Schweiz Med Wochenschr; 1987 Feb; 117(6):187-92. PubMed ID: 3551060
    [TBL] [Abstract][Full Text] [Related]  

  • 23. GAD antibodies seldom disappear in slowly progressive IDDM.
    Kobayashi T; Nakanishi K; Okubo M; Murase T; Kosaka K
    Diabetes Care; 1996 Sep; 19(9):1031. PubMed ID: 8875105
    [No Abstract]   [Full Text] [Related]  

  • 24. [Differential diagnostic problems in juvenile diabetes mellitus].
    Winkler G; Gerö L; Pánczél P; Merétey K; Grósz A; Kautzky L; Halmos T
    Orv Hetil; 1985 Oct; 126(41):2517-23. PubMed ID: 3900873
    [No Abstract]   [Full Text] [Related]  

  • 25. [Insulin and C-peptide in the blood serum of children and adolescents with diabetes mellitus].
    Balabolkin MI; Zubovskiĭ GA; Stuliĭ LA; Domanova VT
    Med Radiol (Mosk); 1980 Jun; 25(6):34-7. PubMed ID: 6993830
    [No Abstract]   [Full Text] [Related]  

  • 26. [Current interpretation of type 2 diabetes mellitus (NIDDM)].
    Halmos T
    Orv Hetil; 1995 May; 136(22):1147-55. PubMed ID: 7761077
    [TBL] [Abstract][Full Text] [Related]  

  • 27. C-peptide used in the estimation of islet beta-cell function in diabetes.
    Gjessing HJ
    Dan Med Bull; 1992 Oct; 39(5):438-52. PubMed ID: 1424818
    [No Abstract]   [Full Text] [Related]  

  • 28. Clinical investigations into the modification of the effect of endogenous and exogenous insulin by human proinsulin in type II and type I diabetics.
    Bellenberg S; Schröder KE; Schlüter KJ; Bottermann P; Zilker T; Gray P
    Horm Metab Res Suppl; 1988; 18():77-83. PubMed ID: 3056817
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Random C-peptide in the classification of diabetes.
    Berger B; Stenström G; Sundkvist G
    Scand J Clin Lab Invest; 2000 Dec; 60(8):687-93. PubMed ID: 11218151
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Latent autoimmune diabetes in adults: a guide for the perplexed.
    Gale EA
    Diabetologia; 2005 Nov; 48(11):2195-9. PubMed ID: 16193287
    [No Abstract]   [Full Text] [Related]  

  • 31. Distinguishing type 1 and type 2 diabetes at diagnosis. What is the problem?
    Rosenbloom AL
    Pediatr Diabetes; 2007 Apr; 8(2):51-2. PubMed ID: 17448126
    [No Abstract]   [Full Text] [Related]  

  • 32. [The remission stage in juvenile diabetes].
    Buysschaert M; Ketelslegers JM; Van Halle B; Lambert AE
    Acta Clin Belg; 1980; 35(5):293-9. PubMed ID: 7013394
    [No Abstract]   [Full Text] [Related]  

  • 33. The C-peptide response to glucagon injections in IDDM and NIDDM patients.
    Poulsen S; Billesbølle P; Kølendorf K; Thorsteinsson B
    Horm Metab Res; 1985 Jan; 17(1):39-40. PubMed ID: 3967844
    [No Abstract]   [Full Text] [Related]  

  • 34. Diabetes mellitus: current concepts.
    Berelowitz M; Pensak ML
    Am J Otol; 1986 Mar; 7(2):157-8. PubMed ID: 3515959
    [No Abstract]   [Full Text] [Related]  

  • 35. The classification of diabetes mellitus in children and adolescents.
    Drash AL
    Acta Paediatr Jpn; 1987 Jun; 29(3):325-34. PubMed ID: 3144857
    [No Abstract]   [Full Text] [Related]  

  • 36. Antidiabetogenic effect of glucagon-like peptide-1 (7-36)amide in normal subjects and patients with diabetes mellitus.
    Gutniak M; Orskov C; Holst JJ; Ahrén B; Efendic S
    N Engl J Med; 1992 May; 326(20):1316-22. PubMed ID: 1348845
    [TBL] [Abstract][Full Text] [Related]  

  • 37. C-peptide and free insulin determinations in type I diabetes; relationships with metabolic control and insulin therapy.
    Taskinen MR; Groop L
    Ann Clin Res; 1984; 16(2):118-27. PubMed ID: 6380385
    [No Abstract]   [Full Text] [Related]  

  • 38. Cyclosporin-A treatment for early insulin-dependent diabetes mellitus: first experience in Israel.
    Kisch ES; Yust I
    Isr J Med Sci; 1989 Jul; 25(7):414-6. PubMed ID: 2759840
    [No Abstract]   [Full Text] [Related]  

  • 39. [Insulin receptors in diabetes mellitus].
    He R; Cui Y; Zhu X
    Zhonghua Nei Ke Za Zhi; 1997 Sep; 36(9):607-9. PubMed ID: 10436971
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High-dose gammaglobulin therapy in six children with newly diagnosed insulin-dependent diabetes mellitus.
    Urakami T; Hanaoka Y; Fujita H; Kitagawa T
    Acta Paediatr Jpn; 1987 Jun; 29(3):355-60. PubMed ID: 2462777
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.